ROR1 and B-cell chronic lymphocytic leukemia: The enhanced expression of ROR1 is associated with malignancies of several tissues, including hematological cancers such as chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), as well as ovarian, breast, prostate, lung, melanoma and colorectal cancers (Figure 1) [15].